RIGEL PHARMACEUTICALS INC Contracts & Agreements

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on March 5, 2024)

Executive Severance Plan, as amended (Filed With SEC on November 7, 2023)

Amendment No. 1 to the License and Collaboration Agreement (Filed With SEC on November 7, 2023)

Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 1, 2023)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on August 1, 2023)

Amendments 1, 2 and 3 to License and Transition Services Agreement with Forma Therapeutics, Inc (Filed With SEC on August 1, 2023)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on March 7, 2023)

Sublease Agreement with Atara Biotherapheutics, Inc., dated October 28, 2022 (Filed With SEC on March 7, 2023)

Offer Letter from Rigel Pharmaceuticals, Inc. to Raymond Furey, dated November 17, 2022 (Filed With SEC on March 7, 2023)

Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 2, 2022)

Amendment No. Six to Build-to-Suit Lease between Rigel Pharmaceuticals, Inc. and HCP BTC, LLC, dated March 16, 2022 (Filed With SEC on May 3, 2022)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on May 3, 2022)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on March 1, 2022)

Non-Employee Director Compensation Policy (Filed With SEC on March 1, 2022)

First Amendment to the Credit and Security Agreement with MidCap Financial Trust dated April 2, 2021 (Filed With SEC on March 1, 2022)

Second Amendment to the Credit and Security Agreement with MidCap Financial Trust, dated February11, 2022 (Filed With SEC on March 1, 2022)

2022 Cash Incentive Plan (Filed With SEC on January 28, 2022)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on November 2, 2021)

Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 3, 2021)

Rigel Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan, as amended (Filed With SEC on August 3, 2021)

License and Collaboration Agreement by and between the Company and Eli Lilly and Company, dated February 28, 2021 (Filed With SEC on May 5, 2021)

Non-employee Directors Compensation Policy (Filed With SEC on May 5, 2021)

2021 Cash Incentive Plan (Filed With SEC on February 3, 2021)

Offer Letter from Rigel Pharmaceuticals, Inc. to David Santos, dated July 13, 2020 (Filed With SEC on November 5, 2020)

Open Market Sale AgreementSM, dated August 4, 2020, by and between Rigel Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on August 4, 2020)

Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on August 4, 2020)

Executive Severance Plan as amended (Filed With SEC on May 5, 2020)

Description of Capital Stock (Filed With SEC on February 27, 2020)

Offer Letter from Rigel Pharmaceuticals, Inc. to Wolfgang Dummer, dated October 3, 2019 (Filed With SEC on February 27, 2020)

2020 Cash Incentive Plan (Filed With SEC on November 22, 2019)

Credit and Security Agreement, dated as of September 27, 2019, by and between the Registrant and MidCap Financial Trust (Filed With SEC on November 5, 2019)

2018 Equity Incentive Plan, as amended (Filed With SEC on August 6, 2019)

Exclusive Commercialization License Agreement between Rigel and Grifols Worldwide Operations Limited, dated January 22, 2019 (Filed With SEC on May 7, 2019)

Supply Agreements with Kissei Pharmaceutical Co., Ltd (Filed With SEC on February 28, 2019)

Collaboration and License Agreements with Kissei Pharmaceutical Co., Ltd (Filed With SEC on February 28, 2019)

2019 Cash Incentive Plan (Filed With SEC on February 1, 2019)

2018 Equity Incentive Plan (Filed With SEC on August 8, 2018)

Offer Letter from Rigel Pharmaceuticals, Inc. to Dean Schorno, dated May 22, 2018 (Filed With SEC on August 8, 2018)

Executive Severance Plan (Filed With SEC on May 1, 2018)

Underwriting Agreement, dated as of April 19, 2018, by and among Rigel Pharmaceuticals, Inc. and Jefferies LLC and Piper Jaffray & Co (Filed With SEC on April 20, 2018)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on March 6, 2018)

Amendment No. Five to BuildtoSuit Lease between Rigel Pharmaceuticals, Inc. and HCP BTC, LLC, dated July 24, 2017 (Filed With SEC on March 6, 2018)

Transition and Separation Agreement between Rigel Pharmaceuticals, Inc. and Ryan Maynard dated December 14, 2017 (Filed With SEC on March 6, 2018)

2018 Cash Incentive Plan (Filed With SEC on February 2, 2018)

Rigel Pharmaceuticals, Inc. Inducement Plan, as amended (Filed With SEC on November 7, 2017)

Underwriting Agreement, dated as of October 4, 2017, by and among Rigel Pharmaceuticals, Inc., Jefferies LLC and BMO Capital Markets Corp (Filed With SEC on October 5, 2017)

RIGEL PHARMACEUTICALS, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED: MARCH 23, 2011 APPROVED BY STOCKHOLDERS MAY 19, 2011 AMENDED FEBRUARY 3, 2012 APPROVED BY STOCKHOLDERS MAY 22, 2012... (Filed With SEC on August 1, 2017)

AMENDMENT NO. 1 TO SALES AGREEMENT (Filed With SEC on May 30, 2017)

Rigel Pharmaceuticals, Inc. Inducement Plan Adopted by the Compensation Committee: October 10, 2016 Amended by the Compensation Committee: January 3, 2017 (Filed With SEC on March 7, 2017)

2017 CASH INCENTIVE PLAN (Filed With SEC on February 8, 2017)

20,000,000 Shares Rigel Pharmaceuticals, Inc. UNDERWRITING AGREEMENT (Filed With SEC on January 31, 2017)

SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on November 1, 2016)

RIGEL PHARMACEUTICALS, INC. INDUCEMENT PLAN ADOPTED BY THE COMPENSATION COMMITTEE: October 10, 2016 (Filed With SEC on October 11, 2016)

RIGEL PHARMACEUTICALS, INC. INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on October 11, 2016)

SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 2, 2016)

CLINICAL RESEARCH CONSULTING AGREEMENT (Filed With SEC on August 2, 2016)

RIGEL PHARMACEUTICALS, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED: MARCH 23, 2011 APPROVED BY STOCKHOLDERS MAY 19, 2011 AMENDED FEBRUARY 3, 2012 APPROVED BY STOCKHOLDERS MAY 22, 2012... (Filed With SEC on August 2, 2016)

2016 CASH INCENTIVE PLAN (Filed With SEC on January 29, 2016)

RIGEL PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on August 18, 2015)

2015 CASH INCENTIVE PLAN (Filed With SEC on January 30, 2015)

2014 CASH INCENTIVE PLAN (Filed With SEC on May 27, 2014)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN ADOPTED AUGUST 18, 2000 APPROVED BY STOCKHOLDERS SEPTEMBER 11, 2000 EFFECTIVE DATE: DECEMBER 4, 2000... (Filed With SEC on May 7, 2014)

2013 CASH INCENTIVE PLAN (Filed With SEC on February 14, 2013)

13,685,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 3, 2012)

RIGEL PHARMACEUTICALS, INC. 2000 EQUITY INCENTIVE PLAN ADOPTED JANUARY 27, 2000 APPROVED BY STOCKHOLDERS MARCH 15, 2000 AMENDED DECEMBER 13, 2002 AMENDED AND RESTATED APRIL 24,... (Filed With SEC on August 7, 2012)

RIGEL PHARMACEUTICALS, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED: MARCH 23, 2011 APPROVED BY STOCKHOLDERS MAY 19, 2011 AMENDED FEBRUARY 3, 2012 APPROVED BY STOCKHOLDERS MAY 22, 2012... (Filed With SEC on August 7, 2012)

2012 Cash Incentive Plan (Filed With SEC on February 8, 2012)

RIGEL PHARMACEUTICALS, INC. 2000 EQUITY INCENTIVE PLAN AND 2011 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS) (Filed With SEC on November 1, 2011)

RIGEL PHARMACEUTICALS, INC. 2000 EQUITY INCENTIVE PLAN ADOPTED JANUARY 27, 2000 APPROVED BY STOCKHOLDERS MARCH 15, 2000 AMENDED DECEMBER 13, 2002 AMENDED AND RESTATED APRIL 24,... (Filed With SEC on August 2, 2011)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN ADOPTED AUGUST 18, 2000 APPROVED BY STOCKHOLDERS SEPTEMBER 11, 2000 EFFECTIVE DATE: DECEMBER 4, 2000... (Filed With SEC on August 2, 2011)

RIGEL PHARMACEUTICALS, INC. 2011 EQUITY INCENTIVE PLAN ADOPTED: MARCH 23, 2011 APPROVED BY STOCKHOLDERS MAY 19, 2011 TERMINATION DATE: MARCH 23, 2021 (Filed With SEC on August 2, 2011)

Termination Agreement (Filed With SEC on August 2, 2011)

16,300,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 26, 2011)

2011 Base Salaries for Named Executive Officers (Filed With SEC on May 3, 2011)

RIGEL PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 1, 2011)

RIGEL PHARMACEUTICALS, INC. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE PLAN (Filed With SEC on March 1, 2011)

2011 Cash Incentive Plan (Filed With SEC on February 9, 2011)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN ADOPTED AUGUST 18, 2000 APPROVED BY STOCKHOLDERSSEPTEMBER 11, 2000 EFFECTIVE DATE: DECEMBER 4,2000... (Filed With SEC on August 3, 2010)

RIGELPHARMACEUTICALS, INC. 2000EQUITY INCENTIVE PLAN ADOPTEDJANUARY 27, 2000 APPROVEDBY STOCKHOLDERS MARCH 15, 2000 AMENDEDDECEMBER 13, 2002 AMENDEDAND RESTATED APRIL 24, 2003... (Filed With SEC on June 1, 2010)

2010Cash Incentive Plan (Filed With SEC on June 1, 2010)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCKOPTION PLAN ADOPTED AUGUST 18, 2000 APPROVEDBY STOCKHOLDERS SEPTEMBER 11, 2000 EFFECTIVEDATE: DECEMBER 4, 2000... (Filed With SEC on May 4, 2010)

RIGEL PHARMACEUTICALS, INC. 2000 EMPLOYEE STOCK PURCHASE PLAN APPROVED BY THE BOARD OF DIRECTORS AUGUST 18, 2000 APPROVED BY STOCKHOLDERS SEPTEMBER 11, 2000 AMENDED AND RESTATED... (Filed With SEC on May 4, 2010)

LICENSEAND COLLABORATION AGREEMENT (Filed With SEC on May 4, 2010)

2009Base Salaries for Named Executive Officers (Filed With SEC on March 2, 2010)

2010Base Salaries for Named Executive Officers (Filed With SEC on March 2, 2010)

AMENDMENTNO. TWO TO BUILD-TO-SUIT LEASE (Filed With SEC on November 3, 2009)

AMENDMENTNO. THREE TO BUILD-TO-SUIT LEASE (Filed With SEC on November 3, 2009)

13,000,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on September 17, 2009)

RIGELPHARMACEUTICALS, INC. 2000EQUITY INCENTIVE PLAN ADOPTEDJANUARY 27, 2000 APPROVEDBY STOCKHOLDERS MARCH 15, 2000 AMENDEDDECEMBER 13, 2002 AMENDEDAND RESTATED APRIL 24, 2003... (Filed With SEC on August 4, 2009)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCKOPTION PLAN ADOPTED AUGUST 18, 2000 APPROVEDBY STOCKHOLDERS SEPTEMBER 11, 2000 EFFECTIVEDATE: DECEMBER 4, 2000... (Filed With SEC on August 4, 2009)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on May 5, 2009)

AMENDMENT NO. FOUR TO BUILD-TO-SUIT LEASE (Filed With SEC on May 5, 2009)

2009 Cash Incentive Plan (Filed With SEC on April 1, 2009)

RIGELPHARMACEUTICALS, INC. AMENDEDAND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on February 27, 2009)

RIGEL PHARMACEUTICALS, INC. AMENDED AND RESTATED CHANGE OF CONTROL SEVERANCE PLAN (Filed With SEC on February 27, 2009)

RIGEL PHARMACEUTICALS, INC. 2000 EMPLOYEE STOCK PURCHASE PLAN APPROVED BY THE BOARD OF DIRECTORS AUGUST 18, 2000 APPROVED BY STOCKHOLDERS SEPTEMBER 11, 2000 AMENDED AND RESTATED... (Filed With SEC on February 27, 2009)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCK OPTIONPLAN ADOPTED AUGUST 18, 2000 APPROVED BY STOCKHOLDERS SEPTEMBER 11,2000 EFFECTIVE DATE: DECEMBER 4, 2000... (Filed With SEC on August 5, 2008)

2008Compensation Information for Executive Officers (Filed With SEC on May 6, 2008)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCKOPTION PLAN ADOPTED AUGUST 18, 2000 APPROVEDBY STOCKHOLDERS SEPTEMBER 11, 2000 EFFECTIVEDATE: DECEMBER 4, 2000... (Filed With SEC on March 7, 2008)

2008Base Salaries for Named Executive Officers (Filed With SEC on March 7, 2008)

2008 Cash IncentivePlan (Filed With SEC on February 26, 2008)

2007Bonus Payouts for Named Executive Officers (Filed With SEC on February 14, 2008)

5,000,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 1, 2008)

RIGELPHARMACEUTICALS, INC. EMPLOYMENTAGREEMENT (Filed With SEC on December 20, 2007)

RIGELPHARMACEUTICALS, INC. CHANGE OFCONTROL SEVERANCE PLAN (Filed With SEC on December 20, 2007)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEEDIRECTORS STOCK OPTION PLAN ADOPTED AUGUST 18, 2000 APPROVED BY STOCKHOLDERSSEPTEMBER 11, 2000 EFFECTIVE DATE: DECEMBER4, 2000 AMENDED... (Filed With SEC on November 6, 2007)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCKOPTION PLAN ADOPTED AUGUST 18, 2000 APPROVED BY STOCKHOLDERS SEPTEMBER 11, 2000 EFFECTIVE DATE: DECEMBER 4, 2000... (Filed With SEC on August 7, 2007)

INDEMNITYAGREEMENT (Filed With SEC on May 10, 2007)

5,000,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on May 3, 2007)

2007Base Salaries for Named Executive Officers (Filed With SEC on February 2, 2007)

2007Cash Incentive Plan (Filed With SEC on February 2, 2007)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on November 7, 2006)

2006 Bonus Plan (Filed With SEC on August 2, 2006)

2006 Base Salaries for NamedExecutive Officers (Filed With SEC on January 30, 2006)

3,650,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 15, 2005)

RIGELPHARMACEUTICALS, INC. 2000 Equity Incentive Plan Adopted January 27, 2000 Approved By Stockholders March 15, 2000 Amended December 13, 2002 Amended and Restated April 24,... (Filed With SEC on June 6, 2005)

RIGEL PHARMACEUTICALS, INC. 2000 NON-EMPLOYEE DIRECTORS STOCK OPTION PLAN ADOPTED AUGUST 18, 2000 APPROVED BY STOCKHOLDERS SEPTEMBER 11, 2000 EFFECTIVE DATE: DECEMBER 4, 2000... (Filed With SEC on June 6, 2005)

COLLABORATIVERESEARCH AND LICENSE AGREEMENT (Filed With SEC on May 6, 2005)

2005Base Salaries for Named Executive Officers (Filed With SEC on February 2, 2005)

2005Cash Incentive Plan (Filed With SEC on February 2, 2005)

RIGELPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT Warrant No. CS-15 217,686 Shares June 26, 2003 (Filed With SEC on March 12, 2004)

RIGELPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT Warrant No. CS-17 33,947 Shares June 26, 2003 (Filed With SEC on March 12, 2004)

RIGELPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT Warrant No. CS-16 8,008 Shares June 26, 2003 (Filed With SEC on March 12, 2004)

RIGELPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT Warrant No. CS-18 776 Shares June 26, 2003 (Filed With SEC on March 12, 2004)

RIGELPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT Warrant No. CS-21 173,611 Shares June 26, 2003 (Filed With SEC on March 12, 2004)

RIGEL PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT Warrant No. CS-9 48,585 Shares June 26, 2003 (Filed With SEC on March 12, 2004)

RIGEL PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 12, 2004)

RIGELPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT (Filed With SEC on March 12, 2004)

RIGEL PHARMACEUTICALS, INC. COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 12, 2004)

RIGELPHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT (Filed With SEC on March 12, 2004)

RIGEL PHARMACEUTICALS, INC. SECONDINVESTOR RIGHTS AGREEMENT June 26, 2003 TABLE OFCONTENTS (Filed With SEC on March 12, 2004)

3,165,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 20, 2004)

RGL RIGEL PHARMACEUTICALS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CUSIP 766559 60 3 (Filed With SEC on June 24, 2003)

RIGEL PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT APRIL 29, 2003 TABLE OFCONTENTS (Filed With SEC on May 2, 2003)

RIGEL PHARMACEUTICALS, INC. COMMONSTOCK PURCHASE WARRANT (Filed With SEC on May 2, 2003)

RIGELPHARMACEUTICALS, INC. SECOND INVESTOR RIGHTS AGREEMENT [ ][ ], 2003 Table of Contents (Filed With SEC on May 2, 2003)

VOTINGAGREEMENT (Filed With SEC on May 2, 2003)

AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 31, 2003)

COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 31, 2003)

COMMONSTOCK PURCHASE WARRANT (Filed With SEC on March 31, 2003)

RIGELPHARMACEUTICALS, INC. 2000 EQUITY INCENTIVE PLAN ADOPTED JANUARY 27, 2000 APPROVED BY STOCKHOLDERS MARCH 15, 2000 AMENDED DECEMBER 13, 2002 TERMINATION DATE: JANUARY 26, 2010 (Filed With SEC on March 31, 2003)

RIGELPHARMACEUTICALS, INC. 2001 NON-OFFICER EQUITY INCENTIVEPLAN ADOPTED JULY 19, 2001 AMENDED DECEMBER 13, 2002 STOCKHOLDER APPROVAL NOT REQUIRED (Filed With SEC on March 31, 2003)

AMENDMENT NO. ONE TO BUILD-TO-SUIT LEASE (Filed With SEC on March 31, 2003)

MASTEREQUIPMENT LEASE AGREEMENT Agreement No ###-###-#### Dated: December 23, 2002 (Filed With SEC on March 31, 2003)

WARRANT TO PURCHASE STOCK (Filed With SEC on November 14, 2002)

RIGEL PHARMACEUTICALS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on November 14, 2002)

COLLABORATION AGREEMENT (Filed With SEC on November 14, 2002)

STOCKSUBSCRIPTION WARRANT ToPurchase Common Stock of RigelPharmaceuticals, Inc. DATEOF INITIAL ISSUANCE: January 24, 2002 (Filed With SEC on May 14, 2002)

SECOND AMENDMENT TO COLLABORATIONAGREEMENT (Filed With SEC on November 13, 2001)

LICENSE AND RESEARCH AGREEMENT (Amended and Restated) (Filed With SEC on November 13, 2001)

Category

Industry

Companies

Contracts

RIGEL PHARMACEUTICALS INC Contracts & Agreements